A Randomized Double Blinded Controlled Trial for the Treatment of Persistent Post-concussion Symptoms With Psilocybin Assisted Therapy: A Safety and Feasibility Trial
Phase: PHASE1 | Sponsor: University of Calgary | Compound: Psilocybin
- Status
- recruiting
- Institution
- University of Calgary
- Start date
- 2025-05-27
- End date
- 2027-03-30
- Registry ID
- NCT06615908
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.